Home  >  Products  >  RPL14 (ribosomal protein L14 ) Blocking Peptide (the C terminal of RPL14)(100ug)
RPL14 (ribosomal protein L14 ) Blocking Peptide (the C terminal of RPL14)(100ug)

RPL14 (ribosomal protein L14 ) Blocking Peptide (the C terminal of RPL14)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-RPL14 Antibody (ARP61692_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61692
Size: 100ug
Weight: 24kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L14E family of ribosomal proteins. It contains a basic region-leucine zipper (bZIP)-like domain. The protein is located in the cytoplasm. This gene contains a trinucleotide (GCT) repeat tract whose length is highly polymorphic; these triplet repeats result in a stretch of alanine residues in the encoded protein. Transcript variants utilizing alternative polyA signals and alternative 5'-terminal exons exist but all encode the same protein. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome.
Alternative names: CAG-ISL-7; CTG-B33; L14; MGC88594; RL14; hRL14
See Full Product Listings >